Showing results (131-140 of 195) with videos related to

Sort By:
Pageof 20
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 13, 2023
Brigatinib Versus Alectinib in ALK-Positive NSCLC After Disease Progression on Crizotinib: Results of Phase 3 ALTA-3 TrialJames Chih-Hsin Yang, Geoffrey Liu, Shun Lu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 9, 2024
Tislelizumab Plus Platinum and Etoposide Versus Placebo Plus Platinum and Etoposide as First-Line Treatment for Extensive-Stage SCLC (RATIONALE-312): A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 3 Clinical TrialYing Cheng, Yun Fan, Yanqiu Zhao, et al.
Plant Biotechnology Journal|May 8, 2023
Metabolic engineering and mechanical investigation of enhanced plant autoluminescencePeng Zheng, Jieyu Ge, Jiayi Ji, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 31, 2019
Osimertinib for Patients With Leptomeningeal Metastases Associated With EGFR T790M-Positive Advanced NSCLC: The AURA Leptomeningeal Metastases AnalysisMyung-Ju Ahn, Chao-Hua Chiu, Ying Cheng, et al.
Journal of Cellular Physiology|February 25, 2020
miRNA-192 and -215 activate Wnt/β-catenin signaling pathway in gastric cancer via APCShiqi Deng, Xiaojing Zhang, Ying Qin, et al.
Oncology Reports|December 14, 2018
Inhibition of miR‑194 suppresses the Wnt/β‑catenin signalling pathway in gastric cancerYin Peng, Xiaojing Zhang, Huijuan Lin, et al.
Pageof 20